Fundraising Fox

Evis Hursever

Investor

CEO at Essex Woodlands Healthcare Partners

London

About

Evis Hursever joined Essex Woodlands (EW) in 2011, became Managing Director in 2019, and CEO in 2024. Before joining EW, she spent over a decade in the healthcare industry, serving as a senior manager on the European life sciences and healthcare team at LEK Consulting and earlier working in healthcare investment banking at Merrill Lynch International. She holds a B.A. from Macalester College and a Ph.D. from the University of Pennsylvania.

ContactΒ· self-published, not guessed

Invests in

BiotechDigital HealthHealthtech

Deals Β· 2

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Led

Ascend Advanced Therapies – ABL Inc.Boiron S.A.GermfreeGrundium

Board seats

BiotoscanaEUSA Pharma II

Per the firm's website.

Colleagues at Essex Woodlands Healthcare Partners

Frequently asked questions

Who is Evis Hursever?
Evis Hursever joined Essex Woodlands (EW) in 2011, became Managing Director in 2019, and CEO in 2024. Before joining EW, she spent over a decade in the healthcare industry, serving as a senior manager on the European life sciences and healthcare team at LEK Consulting and earlier working in healthcare investment banking at Merrill Lynch International. She holds a B.A. from Macalester College and a Ph.D. from the University of Pennsylvania.
Where does Evis Hursever work?
Evis Hursever is CEO at Essex Woodlands Healthcare Partners.
What does Evis Hursever invest in?
Evis Hursever invests in Biotech, Digital Health, Healthtech.
What boards does Evis Hursever sit on?
Evis Hursever holds tracked board seats at Biotoscana, EUSA Pharma II.
What companies has Evis Hursever invested in?
Investments tracked here include Ascend Advanced Therapies – ABL Inc., Boiron S.A., Cognate Bioservices, Germfree, Grundium, Laboratoires Majorelle.
Does Evis Hursever lead rounds?
Yes β€” Evis Hursever has led 6 tracked investments.